immunotherapy for patients with resectable nsclc & driver mutation-targeted therapies in lung cancer
Published 11 months ago • 32 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
2:05
immunotherapy for patients with resectable nsclc and a driver mutation
-
6:00
immunotherapy for patients with driver mutation - lung cancer video library
-
2:52
before surgery, patients with resectable nsclc & driver mutation - targeted therapies in lung cancer
-
3:12
targeted therapy before surgery in patients with resectable nsclc and driver mutation
-
19:05
what we know about immunotherapy treatments for lung cancer
-
2:51
neoadjuvant treatment for patients with nsclc - targeted therapies in lung cancer 2023
-
16:03
grace targeted therapies lung cancer 2021 -the role of chemotherapy in driver positive patients
-
2:00
clinical trial tests nivolumab for patients with rare brain and spine cancers
-
6:52
combination chemotherapy and immunotherapy for patients with high pd-l1 nsclc - 2022 program: lcvl
-
5:31
biomarkers in nsclc - targeted therapies in lung cancer 2023
-
11:36
immunotherapy for lung cancer: currently enrolling clinical trials of combination therapies
-
9:35
grace targeted therapies lung cancer 2021 - single agent immunotherapy if driver mutation positive?
-
7:39
chemotherapy and immunotherapy for patients with kras mutations - asco lung review 2022
-
4:40
ntrk nsclc: treatment options and side effects - targeted therapies in lung cancer 2023
-
3:02
the future of ret nsclc treatment - targeted therapies in lung cancer 2023
-
4:34
immunotherapy for first line therapy of advanced nsclc
-
4:10
egfr mutations in advanced nsclc - targeted therapies in lung cancer 2023
-
42:48
immunotherapy for lung cancer
-
6:40:28
full video ondemand -targeted therapies patient forum 2022 - for those living with lung cancer